Gene: DOK6
Official Full Name: docking protein 6provided by HGNC
Gene Summary: DOK6 is a member of the DOK (see DOK1; MIM 602919) family of intracellular adaptors that play a role in the RET (MIM 164761) signaling cascade (Crowder et al., 2004 [PubMed 15286081]).[supplied by OMIM, Mar 2008]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO28102 | DOK6 Knockout cell line (HEK293) | Human | DOK6 | 1:3~1:6 | Negative | Online Inquiry |
DOK6 Gene Knockout Cell Lines are specially engineered cellular models in which the DOK6 gene has been selectively disrupted or inactivated. These cell lines provide invaluable tools for researchers seeking to understand the functional role of DOK6 in various biological processes, including signal transduction, cell proliferation, and differentiation. With the knockout of the DOK6 gene, scientists can effectively elucidate the downstream effects on cellular pathways, aiding in the discovery of new therapeutic targets.
The primary mechanism through which DOK6 Knockout Cell Lines function is the absence of the DOK6 protein, a critical adaptor molecule involved in regulating key signaling pathways such as Ras and PI3K/Akt pathways. This absence allows for the examination of cellular responses in a controlled environment, enabling researchers to study gene interactions and their implications in disease states, particularly in cancer research and metabolic disorders.
Scientifically, these cell lines hold substantial importance as they allow for targeted investigations into gene functions and the molecular mechanics underlying various conditions. In clinical settings, findings derived from experiments using DOK6 Knockout Cell Lines could potentially lead to novel diagnostic markers or therapeutic approaches, addressing significant healthcare challenges.
Compared to traditional methods of gene manipulation, such as siRNA or transient transfection, DOK6 Knockout Cell Lines provide a stable and reproducible platform for long-term studies. Their robustness and reliability enhance experimental outcomes, making them a preferred choice for researchers. Additionally, they facilitate high-throughput screening applications, thus accelerating the pace of discovery in translational research.
For researchers, clinicians, and biotechnologists, the DOK6 Gene Knockout Cell Lines represent a pivotal asset for advancing biological understanding and therapeutic advancements. Our company specializes in producing high-quality, genetically modified cell lines backed by rigorous scientific validation, empowering our users to achieve impactful results in their studies.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.